Nomura Asset Management CO LTD Crispr Therapeutics Ag Transaction History

Nomura Asset Management CO LTD

12 transactions

Quarter	Operation	Price Per share	shares change
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $0 - $0	0 New
Q4 2021 Feb 01, 2022	SELL	$70.09 - $111.29 $0 - $0	0 Closed
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $0 - $0	0 New
Q2 2021 Aug 06, 2021	BUY	$100.84 - $161.89 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $0 - $0	0 New
Q2 2019 Aug 13, 2019	SELL	$35.45 - $48.2 $0 - $0	0 Closed
Q1 2019 May 10, 2019	BUY	$28.02 - $40.87 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$28.02 - $40.87 $0 - $0	0 New
Q4 2018 Feb 12, 2019	BUY	$22.73 - $42.34 $0 - $0	0 New
Q3 2018 Nov 07, 2018	BUY	$44.35 - $65.71 $0 - $0	0 New
Q2 2018 Aug 03, 2018	BUY	$42.62 - $73.59 $0 - $0	0 New

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.23B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.